161 related articles for article (PubMed ID: 38397996)
1. Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
Stevens AM; Terrell M; Rashid R; Fisher KE; Marcogliese AN; Gaikwad A; Rao P; Vrana C; Krueger M; Loken M; Menssen AJ; Cook JA; Keogh N; Alozie M; Oviedo H; Gonzalez AK; Ilangovan T; Kim J; Sandhu S; Redell MS
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397996
[TBL] [Abstract][Full Text] [Related]
2. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.
Zeng M; Ruan Z; Tang J; Liu M; Hu C; Fan P; Dai X
Cancer Cell Int; 2023 Jun; 23(1):120. PubMed ID: 37344821
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells.
Kawashima N; Ishikawa Y; Kim JH; Ushijima Y; Akashi A; Yamaguchi Y; Hattori H; Nakashima M; Ikeno S; Kihara R; Nishiyama T; Morishita T; Watamoto K; Ozawa Y; Kitamura K; Kiyoi H
Nat Commun; 2022 Mar; 13(1):1624. PubMed ID: 35338146
[TBL] [Abstract][Full Text] [Related]
4. [Knowledge and practice of patient-derived xenograft models in leukemia].
Kato I
Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
Chianese U; Papulino C; Megchelenbrink W; Tambaro FP; Ciardiello F; Benedetti R; Altucci L
Semin Cancer Biol; 2023 Jul; 92():84-101. PubMed ID: 37003397
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of patient-derived xenograft models of pediatric leukemia.
Rogojina A; Klesse LJ; Butler E; Kim J; Zhang H; Xiao X; Guo L; Zhou Q; Hartshorne T; Garcia D; Weldon K; Holland T; Bandyopadhyay A; Prado LP; Wang S; Yang DM; Langevan AM; Zou Y; Grimes AC; Assanasen C; Gidvani-Diaz V; Zheng S; Lai Z; Chen Y; Xie Y; Tomlinson GE; Skapek SX; Kurmasheva RT; Houghton PJ; Xu L
iScience; 2023 Nov; 26(11):108171. PubMed ID: 37915590
[TBL] [Abstract][Full Text] [Related]
7. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
Cieniewicz B; Uyeda MJ; Chen PP; Sayitoglu EC; Liu JM; Andolfi G; Greenthal K; Bertaina A; Gregori S; Bacchetta R; Lacayo NJ; Cepika AM; Roncarolo MG
Haematologica; 2021 Oct; 106(10):2588-2597. PubMed ID: 33054128
[TBL] [Abstract][Full Text] [Related]
8. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenografts as compatible models for precision oncology.
Cho SY
Lab Anim Res; 2020; 36():14. PubMed ID: 32461927
[TBL] [Abstract][Full Text] [Related]
11. Strong concordance between RNA structural and single nucleotide variants identified via next generation sequencing techniques in primary pediatric leukemia and patient-derived xenograft samples.
Barwe SP; Gopalakrisnapillai A; Mahajan N; Druley TE; Kolb EA; Crowgey EL
Genomics Inform; 2020 Mar; 18(1):e6. PubMed ID: 32224839
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
[TBL] [Abstract][Full Text] [Related]
13. Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation.
Yafei J; Haoran M; Wenyan J; Linghang X; Kai T; Gangyang W; Zhuoying W; Jing H; Mengkai Y; Yujie T; Yingqi H; Zhengdong C
J Orthop Translat; 2021 Jul; 29():106-112. PubMed ID: 34136349
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia.
Francis OL; Milford TA; Beldiman C; Payne KJ
J Investig Med; 2016 Mar; 64(3):740-4. PubMed ID: 26912005
[TBL] [Abstract][Full Text] [Related]
15. Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency.
Perez MW; Sias-Garcia O; Daramola A; Wei H; Terrell M; Rashid R; Park WD; Duong K; Horton TM; Li F; Cherayil N; Koren JV; Gant VU; Junco JJ; Curry CV; Stevens AM; Lin CY; Yi JS
Blood Adv; 2021 Dec; 5(23):4864-4876. PubMed ID: 34543389
[TBL] [Abstract][Full Text] [Related]
16. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.
Vick B; Rothenberg M; Sandhöfer N; Carlet M; Finkenzeller C; Krupka C; Grunert M; Trumpp A; Corbacioglu S; Ebinger M; André MC; Hiddemann W; Schneider S; Subklewe M; Metzeler KH; Spiekermann K; Jeremias I
PLoS One; 2015; 10(3):e0120925. PubMed ID: 25793878
[TBL] [Abstract][Full Text] [Related]
17. PDX Finder: A portal for patient-derived tumor xenograft model discovery.
Conte N; Mason JC; Halmagyi C; Neuhauser S; Mosaku A; Yordanova G; Chatzipli A; Begley DA; Krupke DM; Parkinson H; Meehan TF; Bult CC
Nucleic Acids Res; 2019 Jan; 47(D1):D1073-D1079. PubMed ID: 30535239
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine.
Morgan KM; Riedlinger GM; Rosenfeld J; Ganesan S; Pine SR
Front Oncol; 2017; 7():2. PubMed ID: 28154808
[TBL] [Abstract][Full Text] [Related]
19. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
20. Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts.
Barwe SP; Huang F; Kolb EA; Gopalakrishnapillai A
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
